Non Culprit Lesion Study

• Status: Completed
• Trial end date: 2019-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the present study is to compare the evolution of non culprit lesions after treatment by BVS versus optimal medical therapy at 2-years follow- up

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Criteria

Inclusion Criteria:

• STEMI and multivessel ASCL

• Successful and uneventful primary PCI

• Non culprit lesion > /= 2.5mm RVD suitable for investigation by FFR

• At least one segment of minimum 10 mm length containing a non culprit lesion

Exclusion Criteria:

• non compliant profile

• patient not able to sign an IC

• cardiogenic shock

• left main disease

• GFR<30ml/min/m2

• previous CABG

• LVEF<35%